Although correlations between levels of enzymes associated with serine/glycine metabolism and tumor prognosis have remained unknown, several previous studies have shown that high levels of glycolysis-associated enzymes, including Glut-1 and CA9, were correlated with unfavorable prognosis in breast cancer [9], [22], [23]. The gene discussed is SLC2A1; the disease is breast cancer.